Cas:784142-83-2 1-(3-Bromophenyl)-5-methyl-1H-pyrazole-3-carboxamide manufacturer & supplier

Chemical Name:1-(3-Bromophenyl)-5-methyl-1H-pyrazole-3-carboxamide

CAS.NO:784142-83-2

Synonyms:1-(3-Bromo-phenyl)-2,5-dihydro-1H-pyrrole

Molecular Formula:C₁₁H₁₀BrN₃O

Molecular Weight:280.12100

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:60.91000

Exact Mass:279.00100

LogP:2.74240

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-(3-Bromo-phenyl)-2,5-dihydro-1H-pyrrole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(3-Bromo-phenyl)-2,5-dihydro-1H-pyrrole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(3-Bromo-phenyl)-2,5-dihydro-1H-pyrrole Use and application,1-(3-Bromo-phenyl)-2,5-dihydro-1H-pyrrole technical grade,usp/ep/jp grade.

Related News: Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment. 1-(3-Bromophenyl)-5-methyl-1H-pyrazole-3-carboxamide manufacturer Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment. 1-(3-Bromophenyl)-5-methyl-1H-pyrazole-3-carboxamide supplier More than 2,000 new cases were also recorded in the country in the past 24 hours, raising the worldwide total to nearly 14,380, according to Chinese and World Health Organization data. The vast majority of the cases are inside China; about 100 cases have been confirmed in at least 23 other countries. 1-(3-Bromophenyl)-5-methyl-1H-pyrazole-3-carboxamide vendor Analysts at Mizuho Americas, who spoke to Lilly’s management this week, said that may well have now changed. “Overall, it sounds like the approval raises new questions for Lilly (as it does for many of us!),” the firm said in a note to clients. 1-(3-Bromophenyl)-5-methyl-1H-pyrazole-3-carboxamide factory The downstream industry of the pharmaceutical intermediate industry is mainly the production of APIs, and the relationship between APIs and preparations is in the upstream and downstream industry chain. The consumer demand for downstream preparations will directly affect the demand for APIs.